What is the main purpose of the systematic review by Du et al?
The systematic review by Du et al. was designed to assess the risk of cardiovascular events associated with the use of PCSK9 inhibitors in high-risk patients. The review analyzed the data from eight trials and found that PCSK9 inhibitors reduced the risk of CVD events without affecting cardiovascular or all-cause mortality.